• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

症状性克罗恩病患者存在更严重的疲劳及神经认知速度减慢。

Greater Fatigue and Reduced Neurocognitive Speed With Symptomatic Crohn's Disease.

作者信息

Bonhomme Brittaney, Nandi Neilanjan, Berera Shivali, Lee Helen, Leung Galen, Tse Chung Sang, Weiss Alexandra, Nessel Lisa, Ren Yue, Li Hongzhe, Aberra Faten N, Lewis James D

机构信息

Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Division of Gastroenterology and Hepatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Crohns Colitis 360. 2024 Dec 23;7(1):otae069. doi: 10.1093/crocol/otae069. eCollection 2025 Jan.

DOI:10.1093/crocol/otae069
PMID:39742036
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11684080/
Abstract

BACKGROUND

While patients with Crohn's disease commonly report fatigue, an association of Crohn's disease with mild neurocognitive impairment has also been suggested. This study investigated the relationship between Crohn's disease activity, fatigue, and neurocognitive functioning.

METHODS

In this cross-sectional study, adults with Crohn's disease ( = 25) and healthy controls ( = 26) completed the PROMIS Fatigue 7a form and Multidimensional Fatigue Inventory and neurocognitive testing across 6 domains. Symptomatic and endoscopic remission were assessed with a short Crohn's Disease Activity Index and Simple Endoscopic Score for Crohn's Disease. Linear regression adjusting for age and sex was used to compare fatigue and neurocognition among patients with Crohn's disease versus controls and those with active Crohn's disease versus those in remission.

RESULTS

Compared to controls, adults with Crohn's disease reported greater overall and domain-specific fatigue (general, physical, and mental) ( < .05 for all comparisons). Patients in symptomatic remission had significantly less fatigue ( < .05). No differences were found in neurocognitive accuracy or speed between Crohn's disease and controls. Disease activity was not associated with accuracy on neurocognitive testing; however, patients with symptomatic Crohn's disease had longer correct response times for social cognition and episodic memory compared to asymptomatic patients ( < .05). Endoscopic disease activity was associated with longer correct response times for tasks linked to social cognition, episodic memory, and complex cognition ( < .05). These differences persisted after adjusting for fatigue.

CONCLUSIONS

Patients with symptomatic Crohn's disease experience greater fatigue and have slower response times on neurocognitive testing. However, fatigue does not appear to mediate the slower response times.

摘要

背景

虽然克罗恩病患者普遍报告有疲劳症状,但也有人提出克罗恩病与轻度神经认知障碍有关。本研究调查了克罗恩病活动、疲劳与神经认知功能之间的关系。

方法

在这项横断面研究中,患有克罗恩病的成年人(n = 25)和健康对照者(n = 26)完成了患者报告结果测量信息系统疲劳7a量表、多维疲劳量表以及6个领域的神经认知测试。使用简短的克罗恩病活动指数和克罗恩病简易内镜评分评估症状缓解和内镜缓解情况。采用调整年龄和性别的线性回归分析,比较克罗恩病患者与对照者以及活动期克罗恩病患者与缓解期患者之间的疲劳和神经认知情况。

结果

与对照者相比,患有克罗恩病的成年人报告的总体疲劳和特定领域疲劳(全身、身体和精神)程度更高(所有比较P < 0.05)。症状缓解的患者疲劳程度明显更低(P < 0.05)。克罗恩病患者与对照者在神经认知准确性或速度方面未发现差异。疾病活动与神经认知测试的准确性无关;然而,有症状的克罗恩病患者与无症状患者相比,社交认知和情景记忆的正确反应时间更长(P < 0.05)。内镜下疾病活动与社交认知、情景记忆和复杂认知相关任务的正确反应时间更长有关(P < 0.05)。在调整疲劳因素后,这些差异仍然存在。

结论

有症状的克罗恩病患者疲劳程度更高,神经认知测试的反应时间更慢。然而,疲劳似乎并未介导反应时间变慢。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024f/11684080/e39061aefc7b/otae069_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024f/11684080/35af7816c27d/otae069_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024f/11684080/bf948a53bf2a/otae069_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024f/11684080/735678f90cd7/otae069_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024f/11684080/b2971fd8708a/otae069_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024f/11684080/e39061aefc7b/otae069_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024f/11684080/35af7816c27d/otae069_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024f/11684080/bf948a53bf2a/otae069_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024f/11684080/735678f90cd7/otae069_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024f/11684080/b2971fd8708a/otae069_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024f/11684080/e39061aefc7b/otae069_fig4.jpg

相似文献

1
Greater Fatigue and Reduced Neurocognitive Speed With Symptomatic Crohn's Disease.症状性克罗恩病患者存在更严重的疲劳及神经认知速度减慢。
Crohns Colitis 360. 2024 Dec 23;7(1):otae069. doi: 10.1093/crocol/otae069. eCollection 2025 Jan.
2
Visceral adiposity and inflammatory bowel disease.内脏肥胖与炎症性肠病。
Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9.
3
Low dose naltrexone for induction of remission in Crohn's disease.低剂量纳曲酮诱导克罗恩病缓解
Cochrane Database Syst Rev. 2018 Apr 1;4(4):CD010410. doi: 10.1002/14651858.CD010410.pub3.
4
Low dose naltrexone for induction of remission in Crohn's disease.低剂量纳曲酮诱导克罗恩病缓解
Cochrane Database Syst Rev. 2014 Feb 21(2):CD010410. doi: 10.1002/14651858.CD010410.pub2.
5
Cannabis for the treatment of Crohn's disease.大麻用于治疗克罗恩病。
Cochrane Database Syst Rev. 2018 Nov 8;11(11):CD012853. doi: 10.1002/14651858.CD012853.pub2.
6
Psychometric evaluation of the Functional Assessment of chronic illness therapy-fatigue (FACIT-Fatigue) in adults with moderately to severely active Crohn's disease.中度至重度活动性克罗恩病成年患者慢性病治疗功能评估-疲劳量表(FACIT-疲劳)的心理测量学评价
Qual Life Res. 2025 Feb;34(2):509-521. doi: 10.1007/s11136-024-03829-3. Epub 2024 Nov 13.
7
Effectiveness and safety outcomes after long-term (54 weeks) vedolizumab therapy for Crohn's disease: a prospective, real-world observational study including patient-reported outcomes (POLONEZ II).维多珠单抗长期(54周)治疗克罗恩病后的有效性和安全性结果:一项前瞻性、真实世界观察性研究,纳入患者报告结局(POLONEZ II)
Therap Adv Gastroenterol. 2024 Nov 20;17:17562848241293938. doi: 10.1177/17562848241293938. eCollection 2024.
8
Eldelumab [anti-interferon-γ-inducible protein-10 antibody] Induction Therapy for Active Crohn's Disease: a Randomised, Double-blind, Placebo-controlled Phase IIa Study.依得利珠单抗(抗干扰素-γ诱导蛋白 10 抗体)诱导治疗活动期克罗恩病的随机、双盲、安慰剂对照 2a 期研究。
J Crohns Colitis. 2017 Jul 1;11(7):811-819. doi: 10.1093/ecco-jcc/jjx005.
9
Patient-Reported Outcomes Measurement Information System in Children with Crohn's Disease.克罗恩病患儿的患者报告结局测量信息系统
J Pediatr. 2016 Jul;174:153-159.e2. doi: 10.1016/j.jpeds.2016.03.069. Epub 2016 May 2.
10
AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.AGA 临床实践更新:炎症性肠病患者的饮食和营养治疗:专家综述。
Gastroenterology. 2024 Mar;166(3):521-532. doi: 10.1053/j.gastro.2023.11.303. Epub 2024 Jan 23.

本文引用的文献

1
The Burden of Psychiatric Manifestations in Inflammatory Bowel Diseases: A Systematic Review With Meta-analysis.炎症性肠病中心理症状的负担:一项系统评价与荟萃分析
Inflamm Bowel Dis. 2025 May 12;31(5):1441-1459. doi: 10.1093/ibd/izae206.
2
Qualitative and psychometric evaluation of the PROMIS®-Fatigue SF-7a scale to assess fatigue in patients with moderately to severely active inflammatory bowel disease.PROMIS®-疲劳 SF-7a 量表评估中重度活动期炎症性肠病患者疲劳的定性和心理测量学评价。
J Patient Rep Outcomes. 2023 Nov 14;7(1):115. doi: 10.1186/s41687-023-00645-0.
3
Incidence, Prevalence, and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States.
美国炎症性肠病的发病率、患病率和种族与民族分布。
Gastroenterology. 2023 Nov;165(5):1197-1205.e2. doi: 10.1053/j.gastro.2023.07.003. Epub 2023 Jul 20.
4
The Effect of Biological Treatment on Fatigue in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.生物治疗对炎症性肠病疲劳的影响:系统评价和荟萃分析。
Drugs. 2023 Jul;83(10):909-921. doi: 10.1007/s40265-023-01888-3. Epub 2023 May 23.
5
Construction of a computerized adaptive test (CAT-CCNB) for efficient neurocognitive and clinical psychopathology assessment.构建用于高效神经认知和临床精神病理学评估的计算机化自适应测试(CAT-CCNB)。
J Neurosci Methods. 2023 Feb 15;386:109795. doi: 10.1016/j.jneumeth.2023.109795. Epub 2023 Jan 16.
6
The relationship between Central Nervous System morphometry changes and key symptoms in Crohn's disease.中枢神经系统形态计量变化与克罗恩病关键症状之间的关系。
Brain Imaging Behav. 2023 Apr;17(2):149-160. doi: 10.1007/s11682-022-00742-6. Epub 2022 Nov 21.
7
Evaluation of Available Cognitive Tools Used to Measure Mild Cognitive Decline: A Scoping Review.评估用于测量轻度认知衰退的现有认知工具:范围综述。
Nutrients. 2021 Nov 8;13(11):3974. doi: 10.3390/nu13113974.
8
Cognitive impairment in patients with rheumatoid arthritis: A systematic review and meta-analysis.类风湿关节炎患者的认知障碍:系统评价和荟萃分析。
Joint Bone Spine. 2022 May;89(3):105298. doi: 10.1016/j.jbspin.2021.105298. Epub 2021 Oct 14.
9
Cognitive Impairment in Adult Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.成人炎症性肠病认知障碍:系统评价和荟萃分析。
J Acad Consult Liaison Psychiatry. 2021 Jul-Aug;62(4):387-403. doi: 10.1016/j.psym.2020.10.002. Epub 2021 Jan 5.
10
Exploring joint patterns of brain structure and function in inflammatory bowel diseases using multimodal data fusion.利用多模态数据融合技术探索炎症性肠病的脑结构和功能的联合模式。
Neurogastroenterol Motil. 2021 Jun;33(6):e14078. doi: 10.1111/nmo.14078. Epub 2020 Dec 28.